Surgery Partners receives ‘buy’ rating — 5 key notes

Nine analysts gave Nashville, Tenn.-based Surgery Partners a “buy” rating, according to The Cerbat Gem.

Advertisement

Here are five key notes:

1. The analysts have an average 12-month price target of $20.86.

2. On Jan. 17, 2017, Jeffries Group gave the company a $24 price target.

3. Surgery Partners opened Jan. 19, 2017, trading at $18 per share.

4. The company’s market cap. totals $872.87 million.

5. The P/E ratio is 92.78.

More articles on surgery centers:
Christ Hospital’s dispute with St. Elizabeth Healthcare over $24M ASC may wage on for years
Auburn Planning Board to consider surgery center application: 5 things to know
Massachusetts Department of Public Health updates DON regulations for existing freestanding ASCs: 4 key notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

  • Atlanta-based United Digestive is planning an ASC in Watkinsville, Ga., focusing on organic growth to expand its network. The newly-constructed,…

  • At least 25 ASCs have closed over the past five years, a pattern of attrition driven by financial strain, staffing…

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

Advertisement

Comments are closed.